Chimerix (CMRX) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free CMRX Stock Alerts $0.99 +0.02 (+1.83%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | americanbankingnews.comChimerix (NASDAQ:CMRX) Lifted to Hold at StockNews.comMay 14, 2024 | americanbankingnews.comChimerix (NASDAQ:CMRX) Stock Crosses Below 200 Day Moving Average of $1.00May 3, 2024 | marketbeat.comChimerix (NASDAQ:CMRX) Downgraded by StockNews.com to "Sell"StockNews.com cut Chimerix from a "hold" rating to a "sell" rating in a report on Friday.May 3, 2024 | markets.businessinsider.comBuy Rating Justified by Chimerix’s Upcoming Catalysts and Strong FinancialsMay 3, 2024 | marketbeat.comBrokers Offer Predictions for Chimerix, Inc.'s FY2028 Earnings (NASDAQ:CMRX)Chimerix, Inc. (NASDAQ:CMRX - Free Report) - Equities research analysts at Capital One Financial reduced their FY2028 earnings per share estimates for shares of Chimerix in a research report issued on Wednesday, May 1st. Capital One Financial analyst N. Quibria now anticipates that the biopharmacMay 2, 2024 | markets.businessinsider.comStrong Buy Rating for Chimerix on Robust Financials and Promising Drug PipelineMay 2, 2024 | finance.yahoo.comChimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call TranscriptMay 2, 2024 | marketbeat.comChimerix (NASDAQ:CMRX) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPSChimerix (NASDAQ:CMRX - Get Free Report) issued its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.04). Chimerix had a negative net margin of 25,337.96% and a negative return on equity of 37.93%. During the same quarter in the previous year, the firm posted ($0.24) EPS.May 2, 2024 | markets.businessinsider.comChimerix’s Strong Financials and Promising ONC201 Developments Merit Buy RatingMay 2, 2024 | finance.yahoo.comChimerix Inc (CMRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...May 2, 2024 | au.finance.yahoo.comQ1 2024 Chimerix Inc Earnings CallMay 1, 2024 | msn.comChimerix GAAP EPS of -$0.25May 1, 2024 | sfgate.comChimerix: Q1 Earnings SnapshotMay 1, 2024 | globenewswire.comChimerix Reports First Quarter 2024 Financial Results and Provides Operational UpdateApril 30, 2024 | markets.businessinsider.comWhat Wall Street expects from Chimerix's earningsApril 25, 2024 | marketbeat.comChimerix (CMRX) Set to Announce Quarterly Earnings on WednesdayChimerix (NASDAQ:CMRX) will be releasing earnings before the market opens on Wednesday, May 1, Zacks reports.April 24, 2024 | globenewswire.comChimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024April 16, 2024 | globenewswire.comChimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 15, 2024 | finance.yahoo.comWe Think Chimerix (NASDAQ:CMRX) Needs To Drive Business Growth CarefullyMarch 16, 2024 | finance.yahoo.comCMRX Apr 2024 1.000 putMarch 16, 2024 | finance.yahoo.comCMRX Apr 2024 2.000 callMarch 5, 2024 | finance.yahoo.comChimerix Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagMarch 2, 2024 | seekingalpha.comChimerix, Inc. (CMRX) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | seekingalpha.comChimerix: Tackling A Strong Unmet Need With Promising DataMarch 1, 2024 | finance.yahoo.comChimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | marketbeat.comChimerix (NASDAQ:CMRX) Earns "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and set a $11.00 price target on shares of Chimerix in a report on Friday.February 29, 2024 | markets.businessinsider.comBuy Rating Affirmed for Chimerix Amid Progress in Dordaviprone’s Phase III Study and Strong Financial OutlookFebruary 29, 2024 | finanznachrichten.deChimerix, Inc.: Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational UpdateFebruary 29, 2024 | finance.yahoo.comChimerix Inc Reports Fourth Quarter and Full-Year 2023 Financial ResultsFebruary 29, 2024 | globenewswire.comChimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational UpdateFebruary 28, 2024 | benzinga.comPreview: Chimerix's EarningsFebruary 28, 2024 | markets.businessinsider.comChimerix is about to announce its earnings — here's what Wall Street expectsFebruary 27, 2024 | finance.yahoo.comChimerix to Present at TD Cowen 44th Annual Health Care ConferenceFebruary 22, 2024 | finance.yahoo.comChimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024February 22, 2024 | globenewswire.comChimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024February 18, 2024 | finance.yahoo.comChimerix, Inc. (NASDAQ:CMRX) surges 24%; individual investors who own 43% shares profited along with institutionsFebruary 8, 2024 | marketbeat.comChimerix (NASDAQ:CMRX) Shares Cross Below 200-Day Moving Average of $0.99Chimerix (NASDAQ:CMRX) Shares Cross Below 200-Day Moving Average of $0.99January 9, 2024 | msn.comLightning Could Strike Twice for Biotech Penny Stock Chimerix (NASDAQ:CMRX)December 29, 2023 | finance.yahoo.comChimerix Appoints Lisa Decker to Board of DirectorsDecember 14, 2023 | finance.yahoo.comPositive Signs As Multiple Insiders Buy Chimerix StockDecember 4, 2023 | marketwatch.comChimerix Names Michelle LaSpaluto to Chief Financial OfficerDecember 4, 2023 | msn.comChimerix promotes Michelle Laspaluto to CFODecember 4, 2023 | markets.businessinsider.comChimerix Appoints Michelle LaSpaluto As CFONovember 24, 2023 | finance.yahoo.comChimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)November 16, 2023 | msn.comChimerix names Thomas Riga as Chief Operating and Commercial OfficerNovember 16, 2023 | finance.yahoo.comChimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial OfficerNovember 3, 2023 | finance.yahoo.comChimerix (NASDAQ:CMRX) shareholders have endured a 70% loss from investing in the stock five years agoNovember 3, 2023 | finance.yahoo.comChimerix, Inc. (NASDAQ:CMRX) Q3 2023 Earnings Call TranscriptNovember 2, 2023 | finance.yahoo.comChimerix Inc (CMRX) Reports Q3 2023 Financial Results and Operational UpdatesNovember 2, 2023 | msn.comChimerix GAAP EPS of -$0.27 misses by $0.04, revenue of $0.01M misses by $0.08M Get Chimerix News Delivered to You Automatically Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry CMRX Media Mentions By Week CMRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMRX News Sentiment▼0.000.42▲Average Medical News Sentiment CMRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMRX Articles This Week▼21▲CMRX Articles Average Week Get Chimerix News Delivered to You Automatically Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Barinthus Biotherapeutics News Today Spero Therapeutics News Today Oncolytics Biotech News Today Vaccitech News Today BioXcel Therapeutics News Today Marinus Pharmaceuticals News Today ProPhase Labs News Today Milestone Pharmaceuticals News Today Anixa Biosciences News Today Connect Biopharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CMRX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chimerix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
